MAZENasdaq United States
Market cap
$1.586 B
$28.65 +0.42%
Close of 7 Aug 2026
Revenue
$167.5M
#2359 by revenue
Earnings
-$131.1M
Loss-making
Shares outstanding
55,345,261
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Maze Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.